Sanofi nabs U.S. rights to a safer aspirin in $35M Pozen deal

John Carroll Sanofi is handing over a $ 15 million upfront along with promises of $ 20 million in precommercialization milestones to partner with Chapel Hill, NC-based Pozen on a ...

Coherus inks $246M Baxter deal to develop Enbrel biosimilar

John Carroll The biosimilars startup Coherus Biosciences has inked a $ 246 million deal to develop a knockoff of Amgen's blockbuster Enbrel (etanercept, which earned ...

Eisai Enters License Deal for Generic Donepezil

mia.burns Eisai Inc. Announces Non-Exclusive Licensing Agreement with Generic Drug Manufacturer to Provide Generic Version of donepezil HCl 23 mg   WOODCLIFF LAKE, N.J., Aug. 29, ...

Amgen bags Onyx Pharma in $10.4B buyout deal

John Carroll Amgen was the first company to make it to the auction block for Onyx Pharmaceuticals. And in the end, it was the only serious bidder left at the table.  FierceBiotech ...

Stada quickly pulls off deal for OTC maker Thorton & Ross

Eric Palmer Germany's Stada announced only 10 days ago that it was in exclusive talks with the U.K. company. Stada said in a statement today that the deal for about $ 345 million ...

Pharma study shows drop in Q2 deal activity

Ryan McBride After some heavy deal flow in the first three months of 2013, the second quarter showed a 40% slide in deal volume compared with the previous one. FierceBiotech News

Shkreli’s Retrophin zeroes in on $25M financing with ‘major’ pharma deal looming

Ryan McBride Founded and led by hedge fund vet Martin Shkreli, Retrophin has nailed down an agreement to raise $ 25 million to finance development of a preclinical rare-disease drug ...

Pfizer, Sanford-Burnham in Diabetes Deal

barbara.lempert Sanford-Burnham Collaborates with Pfizer to Identify Targets for Treatment of Insulin Resistance and Diabetes LAKE NONA, FLA., August 13, 2013 – Sanford-Burnham ...

Avanir, Merck in Januvia Promotion Deal

barbara.lempert Avanir Pharmaceuticals Announces Diabetes Co-Promotion Agreement with Merck Avanir Institutional Sales Force to Promote JANUVIA® (sitagliptin) Tablets and ...

Roche chief’s comments about deal discipline push shares up

Tracy Staton After Roche chief Severin Schwan said over the weekend that deals have to be "worth it financially," Notenstein analysts added that to their checklist of evidence ...

Bayer Signs Deal with Compugen

mia.burns Germany : Bayer HealthCare signs license AGREEMENT with Compugen Ltd Bayer HealthCare, which is the German-based pharmaceutical with operations in northern New Jersey, ...

Amgen, Onyx huddle on $9.5B deal as other bidders fall away

Tracy Staton Amgen is closing in on a deal for Onyx Pharmaceuticals. The biotech giant is working off a $ 130-per-share offer, or about $ 9.5 billion total–and that's too ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS